Cart summary

You have no items in your shopping cart.

    LJ570

    LJ570

    Catalog Number: orb746495

    DispatchUsually dispatched within 5-10 working days
    $ 4,140.00
    Catalog Numberorb746495
    CategorySmall Molecules
    DescriptionLJ570 is the first PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation. LJ570 is a potent partial agonist of both PPARα and γ subtypes. LJ570 inhibited the Cdk5-mediated phosphorylation of PPARγ at serine 273 that is currently considered the mechanism by which some PPARγ partial agonists exert antidiabetic effects similar to thiazolidinediones, without showing their typical side effects. LJ570 may be useful for treatment of dyslipidemic type 2 diabetes.
    CAS Number[2252488-69-8]
    MW394.46
    SMILESO=C([C@H](CC1C=CC(C2C=CC=CC=2)=CC=1)OC1C=CC(C2C=CC=CC=2)=CC=1)O
    FormulaC27H22O3
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    • LJ570 [orb1298989]

      99.89%

      2252488-69-8

      394.46

      C27H22O3

      50 mg, 25 mg, 1 mL*10mM (in DMSO), 500 mg, 100 mg, 5 mg, 2 mg, 1 mg, 10 mg
    • LJ570 [orb1887566]

      2252488-69-8

      50 mg
    • LJ570 [orb1887567]

      2252488-69-8

      5 mg
    • LJ570 [orb1887568]

      2252488-69-8

      10 mg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars